Sorrento Therapeutics Inc. | Balance Sheet
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
31,717.20
71,955.00
136,785.00
84,986.00
22,352.00
168,627
Total Accounts Receivable
394.20
732.00
2,618.00
2,985.00
3,926.00
4,359
Other Current Assets
520.50
1,228.00
1,615.00
1,683.00
3,422.00
6,578
Total Current Assets
32,631.90
73,915.00
141,018.00
89,654.00
29,700.00
179,564
Net Property, Plant & Equipment
2,439.90
2,277.00
7,246.00
12,707.00
19,345.00
24,384
Total Investments and Advances
-
10,000.00
170,127.00
189,002.00
270,007.00
309,988
Intangible Assets
57,362.20
55,017.00
24,538.00
106,314.00
109,311.00
104,581
Other Assets
148.10
332.00
590.00
3,909.00
3,250.00
5,570
Total Assets
92,582.00
141,541.00
343,519.00
401,586.00
479,776.00
674,725
ST Debt & Current Portion LT Debt
373.90
3,316.00
4,835.00
209.00
-
Accounts Payable
2,153.90
1,656.00
1,339.00
8,282.00
9,911.00
Other Current Liabilities
2,951.90
4,585.00
24,699.00
67,594.00
69,044.00
Total Current Liabilities
5,479.70
9,557.00
30,873.00
76,085.00
78,955.00
Long-Term Debt
4,430.90
8,830.00
4,394.00
47,107.00
5,211.00
Deferred Taxes
14,248.00
12,546.00
49,341.00
53,238.00
15,535.00
Other Liabilities
1,614.30
1,895.00
117,973.00
138,654.00
125,302.00
Total Liabilities
25,772.90
32,828.00
202,581.00
315,084.00
273,166.00
Common Equity (Total)
66,809.10
108,713.00
145,152.00
80,037.00
199,568.00
Total Shareholders' Equity
66,809.10
108,713.00
145,152.00
80,037.00
199,568.00
Total Equity
66,809.10
108,713.00
140,938.00
86,502.00
206,610.00
Liabilities & Shareholders' Equity
92,582.00
141,541.00
343,519.00
401,586.00
479,776.00
Accumulated Minority Interest
-
-
4,214.00
6,465.00
7,042.00
About Sorrento Therapeutics
View Profile
